Humira biosimilar developers: can you find who's taking on AbbVie?
Over 30 companies are looking to compete against Abbvie in the adalimumab space. Can you find them all in our word search?
Archives for December 23, 2016
US FDA delays Ocrevus decision date asking Roche for more manufacturing data
The US FDA has pushed back the review date Roche’s Ocrevus (ocrelizumab) after asking for more data on processes used to manufacture the candidate MS treatment.